Association between hematocrit level and mortality in hemodialysis patients. Case study of the anemic patient.

Allan J Collins, J. Ellefson

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

A large, 4-year, retrospective study of the HCFA end-stage renal disease (ESRD) claims database, Parts A and B, was conducted to determine the association between hematocrit (Hct) level and survival in patients on hemodialysis. Patients who survived the last 6 months of each year and had at least 4 Epoetin alfa claims qualified for the study. Cohort entry years were 1990 through 1993, with the relative risk (RR) of mortality evaluated during the following year. Patients were stratified into four groups on the basis of mean Hct levels in the 6-month entry period: < 27%, 27% to < 30%, 30% to < 33%, and 33% to 36%. Using the 30% to < 33% Hct group as reference (relative risk (RR) = 1), patients whose mean 6-month Hct was in the 33% to 36% range were associated with significantly lower RR of mortality, while patients whose mean 6-month Hct was below 30% were associated with significantly higher RR of mortality. This epidemiologic study highlighted an important association between higher hematocrits in hemodialysis patients and lower RR of mortal.

Original languageEnglish (US)
Pages (from-to)233-236
Number of pages4
JournalNephrology nursing journal : journal of the American Nephrology Nurses' Association
Volume27
Issue number2
StatePublished - Apr 2000

Fingerprint Dive into the research topics of 'Association between hematocrit level and mortality in hemodialysis patients. Case study of the anemic patient.'. Together they form a unique fingerprint.

Cite this